Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
MIR302C: MIR302C is one of the upregulated genes associated with the inhibition of EC migration and proliferation in ESRD-hiPSC-ECs [PMC8685359]. However, MIR302C is not expressed in pulmonary cells [PMC4125569]. The pathway of GSEA enrichment includes MIR302C and is associated with various cancer-related processes [PMC9130929]. MIR302C expression is induced by JMJD2 demethylase binding in its promoter region and reduces H3K9me2 methylation [PMC4501658]. PRP-1, a cytostatic peptide, downregulates MIR302C targets, including stemness markers Nanog and c-Myc [PMC4501658]. Overexpression of miR302s, including MIR302C, induces massive apoptosis in cancer cell lines [PMC4400607]. MIR302C is part of the miR-302 family that plays a key role in pluripotency and cell reprogramming [PMC4433211]. It is also downregulated in pancreatic cancer and associated with age-related decline [PMC6154866][PMC6046043]. Activation of canonical BMP signaling upregulates miR302b and MIR302C expression [PMC4164941]. The miR-302 cluster includes miR-302b, MIR302C, miR-302a, miR- 02d, and miR367 that are highly expressed in embryonic stem cells but decline after differentiation [PMC6722449][PMC7555329].\
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset